Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 dose finding in allergic rhinitis
NCT00697281Phase 2Completed
- Sponsor
- Oxagen
- Start
- May 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timapiprant in allergic rhinitis (AR), sponsored by Oxagen. Started May 2008; status: completed.
02
Drugs
timapiprant
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00697281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697281.